Cardiovascular Risk in Type 2 Diabetic Patients With Asymptomatic Hyperuricemia and Gout

1. Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009; 61:885-892.10.1002/art.24612271426719565556Search in Google Scholar

2. Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyper-uricemia in the US general population: NHANES 2007-2008. Am J Med. 2012; 125(7):679-687.10.1016/j.amjmed.2011.09.03322626509Search in Google Scholar

3. Lai HM, Chen CJ, Su BY, et al. Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences. Rheumatology 2012; 51(4):715-20.10.1093/rheumatology/ker37322179738Search in Google Scholar

4. Carnethon MR, Fortmann SP, Palaniappan L, et al. Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 2003; 158(11):1058-67.10.1093/aje/kwg26014630601Search in Google Scholar

5. Boyle JA, McKiddie M, Buchanan KD, et al. Diabetes mellitus and gout. Blood sugar and plasma insulin responses to oral glucose in normal weight, overweight, and gouty patients. 1969; Annals of the Rheumatic Diseases; 28(4):374-8.10.1136/ard.28.4.37410105055794064Search in Google Scholar

6. Niskanen L, Laaksonen DE, Lindstrom J, et al. Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabetes Care; 29(3):709-11.10.2337/diacare.29.03.06.dc05-146516505534Search in Google Scholar

7. Choi HK, De Vera MA, Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology 2008; 47(10):1567-10.10.1093/rheumatology/ken30518710901Search in Google Scholar

8. Kim SC, Solomon DH. Risk of incident atrial fibrillation in gout: a cohort study. Ann Rheum Dis. 2016; 75(8):1473-8.10.1136/annrheumdis-2015-208161477543926324846Search in Google Scholar

9. Rho YH, Lu N, Peloquin CE et al. Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study. Ann Rheum Dis. 2016; 75(1):91-5.10.1136/annrheumdis-2014-205827438880925277955Search in Google Scholar

10. Pan A, Teng GG, Yuan JM, Koh WP. Bidirectional Association between Diabetes and Gout: the Singapore Chinese Health Study. Scientific reports. 2016 May 10;6:25766. PubMed PMID: 27161168. Pubmed Central PMCID: 4861921.10.1038/srep25766486192127161168Search in Google Scholar

11. Lanaspa MA, Sanchez-Lozada LG, Choi YJ et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287(48):40732-44.10.1074/jbc.M112.399899350478623035112Search in Google Scholar

12. Pontremoli R The role of urate-lowering treatment on cardiovascular and renal disease: evidence from CARES, FAST, ALL-HEART, and FEATHER studies, Current Medical Research and Opinion, 2017,33:sup3, 27-32.10.1080/03007995.2017.137852328952388Search in Google Scholar

13. Kizer JR, Bella JN, Palmieri V et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: The Strong Heart Study (SHS). Am Heart J. 2006; 151(2):412-418.10.1016/j.ahj.2005.04.03116442908Search in Google Scholar

14. Staub D, Meyerhans A, Bundi B, et al. Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke 2006; 37:800-805.10.1161/01.STR.0000202589.47401.c616439703Search in Google Scholar

15. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977, 20(3):895-900.10.1002/art.1780200320856219Search in Google Scholar

16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.10.1001/jama.285.19.248611368702Search in Google Scholar

17. Grundy SM, Cleeman JI, Bairey Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004 Jul 13;110(2):227-39.10.1161/01.CIR.0000133317.49796.0E15249516Search in Google Scholar

18. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.Search in Google Scholar

19. Heine GH, Gerhart MK, Ulrich C, et al. Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. Kidney Int 2005; 68:878-885.10.1111/j.1523-1755.2005.00470.x16014069Search in Google Scholar

20. Lang RM, Beirig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.10.1016/j.echo.2005.10.00516376782Search in Google Scholar

21. Dalbeth N, Pool B, Gamble GD, et al. Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 2010, 62(5):1549-1556.10.1002/art.2735620131281Search in Google Scholar

22. Jørgensen PT, Jensen MT, Mogelvang R, et al. Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics. Diabetes & Vascular Disease Research 2016, 13(5) 321-330.10.1177/147916411664558327208801Search in Google Scholar

23. Negishi K. Echocardiographic feature of diabetic cardiomyopathy: where are we now? Cardiovasc Diagn Ther 2018;8(1):47-56.Search in Google Scholar

24. Lin JC, Lin CL, Chen MC, et al. Gout, not hyperuricemia alone, impairs left ventricular diastolic function. Arthritis Res Ther. 2015; 17: 323.10.1186/s13075-015-0842-8464432126568484Search in Google Scholar

25. Kiechl S, Willeit J. The natural course of atherosclerosis. Part 1: incidence and progression. Arterioscler Thromb Vasc Biol. 1999;19(6):1484-1490.10.1161/01.ATV.19.6.1484Search in Google Scholar

26. Zhang L, Yin JK, Duan YY, et al. Evaluation of carotid artery elasticity changes in patients with type 2 diabetes. Cardiovasc Diabetol. 2014; 13: 39.10.1186/1475-2840-13-39393201724506844Search in Google Scholar

27. Cippoli JA, Ferreira-Sae MC, Martins RP et al. Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study. BMC Cardiovascular Disorders. 2012;12:52.10.1186/1471-2261-12-52341819322800461Search in Google Scholar

28. Çukurova S, Pamuk ÖN, Ünlü E, et al. Subclinical atherosclerosis in gouty arthritis patients: a comparative study. Rheumatol Int. 2012; 32(6):1769-73.10.1007/s00296-011-1900-421442166Search in Google Scholar

29. Montalcini T, Gorgone G, Gazzaruso C, et al. Relation between serum uric acid and carotid intima-meida thickness in healthy postmenopausal women. Intern Emerg Med. 2007; 2(1):19-23.10.1007/s11739-007-0004-3278060617551679Search in Google Scholar

30. Tavil Y, Kaya MG, Oktar SO, et al. Uric acid level and its association with intima-media thickness in patients with hypertension. Atherosclerosis. 2008; 197(1):159-163.10.1016/j.atherosclerosis.2007.03.00817416371Search in Google Scholar

31. Miao Z, Yan S, Wang J, et al. Insulin resistance acts as an independent risk factor exacerbating high-purine diet induced renal injury and knee joint gouty lesions. Inflamm Res. 2009; 58(10):659-68.10.1007/s00011-009-0031-919333726Search in Google Scholar